Cell and Gene therapy are often considered the new frontiers in the fight against devastating diseases, including rare diseases and cancers. Clinical trial outcomes remain consistently encouraging, and the next generation of Cell and Gene therapies show significant potential for many patients and families. We can assist with strategies that move products to market faster, […]
BBCR team experience in biologics for rare diseases included rare cancers and precision medicine can help develop a targeted strategy including studies with fewer patients that control for safety issues. Indications analysis and prioritization Strategic drug assessment Clinical study design and protocol Biomarker strategy Early Clinical Development FDA meeting and submission Pre-ND integrated development plan […]